Reference
Health Canada. Summary Safety Review - Viscous Lidocaine 2% - Assessing the Potential Risk of Severe Side Effects in Infants and Young Children. Internet Document : 29 Aug 2016. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/lidocaine-eng.php
Rights and permissions
About this article
Cite this article
Viscous lidocaine linked with severe ADRs in infants, children. Reactions Weekly 1618, 7 (2016). https://doi.org/10.1007/s40278-016-21012-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-21012-4